Diagnostics
ACD Completes the Second Closing of Series a Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development
Published in Medical Patent Law Weekly, September 16th, 2009
ACD will use the funds to accelerate the development of its proprietary diagnostic tests based on the company's patent pending RNAscope™ technology. "This second closing marks the achievement of our RNAscope™ technology development milestones, including in situ detection of single RNA molecules in blood and FFPE tissues, multiplex analysis, and full assay automation," said Dr. Yuling Luo, Founder, President and CEO of ACD. "We can now offer our...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
More Articles from Medical Patent Law Weekly
- Acacia Research Corporation
Acacia Subsidiary Enters into Settlement Agreement with Symantec - Acacia Research Corporation
Acacia Subsidiary Enters into Settlement and License Agreement with Ricoh Company, Ltd. - Acacia Research Corporation
Acacia Subsidiary Licenses Rule-Based Monitoring Technology to SAP - Addiction Medicine
Catalyst Pharmaceutical Partners Licenses Exclusive Rights to New Class of GABA Aminotransferase Inhibitors From Northwestern University - AltaRock Energy Inc.
AltaRock Energy to Suspend Demonstration Project Drilling While Continuing EGS Development - American Science and Engineering, Inc.
AS&E's Proprietary ZBV Mobile Inspection System Demonstrates Success Around the World with Over 400 Systems Sold to Date - More from this issue of Medical Patent Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
